Recombinate Related Clinical Trials
Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A [Completed]
Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A [Terminated]
Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A [Active, not recruiting]
Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care Settings [Recruiting]
Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A [Completed]
Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting. [Recruiting]
Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients [Recruiting]
Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980 [Completed]
Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) [Completed]
Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII [Recruiting]
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients [Active, not recruiting]
EffeKt Taiwan- Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Taiwan [Recruiting]
Survey of Inhibitors in Plasma-Product Exposed Toddlers [Recruiting]
An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A [Recruiting]
EFFEKT - Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FS [Recruiting]
Kogenate FS Regulatory Post-Marketing Surveillance [Recruiting]
PEGylated rFVIII (BAX 855) in Hemophilia A [Not yet recruiting]
Study Evaluating On-Demand Treatment of Xyntha in Chinese Subjects [Recruiting]
Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia A [Recruiting]
Study Evaluating Pharmacovigilance Of Refacto AF [Recruiting]
Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America [Recruiting]
Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes. [Completed]
Pharmacokinetic Study of ADVATE 3000 IU in Previously Treated Patients With Severe Hemophilia A [Recruiting]
Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects [Not yet recruiting]
Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A [Completed]
Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery [Recruiting]
Hemophilia Adult Prophylaxis Study [Recruiting]
Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment. (SPINART) [Recruiting]
Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery [Recruiting]
A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced) [Recruiting]
Early Prophylaxis Immunologic Challenge (EPIC) Study [Recruiting]
Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery [Recruiting]
Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery [Completed]
Russian Kogenate Pediatric Study [Recruiting]
Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A [Recruiting]
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD) [Recruiting]
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease [Recruiting]
Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101 [Completed]
Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A [Recruiting]
Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A [Recruiting]
Safety and Efficacy of Recombinant Factor VIII (N8) in Male Children Previously Treated With Haemophilia A [Recruiting]
Clot Formation and Clot Stability in Patients With Severe Haemophilia A [Completed]
ADVATE Post Authorization Safety Surveillance [Completed]
Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A [Recruiting]
Study Evaluating Refacto for Pharmacovigilance [Recruiting]
Study Evaluating the Efficacy and Safety of Xyntha™ in Children Less Than 6 Years of Age [Not yet recruiting]
Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients [Recruiting]
Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients [Completed]
BAY14-2222 Continuous Infusion in Surgeries [Completed]
Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor [Recruiting]
Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A [Completed]
Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity [Active, not recruiting]
Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia A [Recruiting]
Study of Recombinant Coagulation Factor VIII Fc Fusion Protein, BIIB 031, in Pediatric PTP Subjects With Hemophilia A [Recruiting]
Genetic Susceptibility to Factor VIII Inhibitors [Recruiting]
Kogenate Liplong Study - BAY 79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A [Recruiting]
Study Evaluating ReFacto AF in Severe Hemophilia A [Completed]
Effect of Recombinant FVIII in Healthy Male Subjects Treated With TB-402 [Recruiting]
Study Evaluating ReFacto in Hemophilia A [Completed]
Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A [Recruiting]
Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A [Recruiting]
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery [Completed]
Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive [Recruiting]
Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients – A Continuation of Clinical Study 069901 [Completed]
Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII [Completed]
Safety and Efficacy of N8 in Haemophilia A Subjects [Recruiting]
Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A [Recruiting]
Study Evaluating Inhibitor Specificity in Hemophilia A [Terminated]
A Study With OPTIVATE® in People With Von Willebrand Disease [Recruiting]
Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation [Completed]
Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia [Recruiting]
Rituximab to Treat Severe Hemophilia A [Recruiting]
Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII [Active, not recruiting]
International Immune Tolerance Study [Recruiting]
Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients [Recruiting]
Cooperative Study of Factor VIII Inhibitors [Completed]
Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia [Completed]
Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX [Recruiting]
Optivate in People With Von Willebrand Disease Undergoing Surgery [Recruiting]
Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women [Completed]
Study Evaluating the Safety of Moroctocog Alfa (AF-CC) in Usual Care Settings [Not yet recruiting]
BAY14-2222 Prophylaxis and Joint Function Improvement (Adults) [Active, not recruiting]
A Phase I Study of Monoclonal Antibody TB-402 in Healthy Male Volunteers [Completed]
Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin [Recruiting]
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study
Observational Study on the Efficacy and Safety of NovoSeven® During "Real-Life" Usage in Germany [Recruiting]
Birth Control Pill vs Birth Control Patch Study [Completed]
Platelet Function And Aggregometry In Patients With Aortic Valve Stenosis [Recruiting]
Almond Dose Response Study. [Completed]
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas [Recruiting]
Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers [Terminated]
The Effect of the Mini-Pill on Blood Factors in Women at Increased Risk for Forming Blood Clots [Recruiting]
Musculoskeletal Function in Hemophilia [Active, not recruiting]
The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots [Recruiting]
Hemostatic Effect of Various Colloid Solutions [Recruiting]
The Von Willebrand Disease (VWD) International Prophylaxis (VIP) Study [Recruiting]
|
